Inhibition of Ubiquitin Specific Peptidase 47 (USP47) was identified as a novel therapeutic target for hematologic malignancies bearing mutant oncoprotein EZH2, according to scientists from the Hefei Institutes of Physical ...
Jan 27, 2022
0
20
Chinese researchers have demonstrated new reconstructable uterus-derived materials (RUMs) that allow almost complete recovery from severe uterine injury. Relevant results were published online in Advanced Materials.
Jan 25, 2022
0
41
The maintenance of healthy and resilient gut microbiota is critical for the quality of life and healthspan of the elderly. Fecal microbiota transplantation (FMT) has been widely used to restore healthy gut microbiota as part ...
Jan 25, 2022
0
24
Type 2 diabetes (T2DM) is a systematic multi-organ metabolic disease, which is characterized by dynamic interplay among different organs.
Jan 24, 2022
0
5
Rapid eye movement (REM) sleep brings about brief but periodic awakenings. In 1966, Dr. Frederick Snyder reported the "sentinel" function of REM could help animals prepare a fight or flight response against potential predator ...
Jan 21, 2022
0
112
Podophyllum sinense, a folk herbal medicine, possesses multiple phytochemicals and extensive pharmaceutical activities. Modern pharmacological studies have indicated that P. sinense has remarkable activities, such as anti-proliferative, ...
Jan 18, 2022
0
2
Chinese scientists recently reported the key role in tumor survival played by a histone-acetylation-regulated long noncoding RNA called lysosome cell death regulator (LCDR), providing a potential diagnostic and therapeutic ...
Jan 17, 2022
0
8
Researchers led by Prof. Dai Jianwu from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences developed a multifunctional scaffold to effectively regulate the immune microenvironment after ...
Jan 13, 2022
0
26
Interleukin-12 (IL-12), a potent inducer of cell-mediated immunity, can stimulate the anti-tumor effector functions of the activated T and NK cells for solid tumors rejection. However, clinical administration of IL-12 has ...
Jan 10, 2022
0
39
Researchers from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences recently have introduced new method to assess the risk of hypertension. Results were published in Frontiers in Public Health.
Dec 20, 2021
0
3
